Ginkgo Bioworks Holdings Inc (MEX:DNA)
MXN 170 (0%) Market Cap: 9.17 Bil Enterprise Value: 9.81 Bil PE Ratio: 0 PB Ratio: 1.13 GF Score: 54/100

Q1 2026 Ginkgo Bioworks Holdings Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: MXN176.13
Daniel Marshall Ginkgo Bioworks Holdings Inc;Senior Manager
Communications and Ownership

Good evening. I'm Daniel Marshall, Senior Manager of Communications and ownership at Ginkgo. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Coen, our CFO. Thanks, as always, for joining us. We're looking forward to updating you on our progress.

As a reminder, during the presentation today, we will be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the SEC to learn more about these risks and uncertainties, including our most recent 10-K.

Today, in addition to updating you on the quarter results, we're going to provide insight into how and why we see autonomous labs like Nebula, our autonomous lab, replacing the laminate, which is where nearly all of biological science is done today. As usual, we'll end with the Q&A session, and I'll take questions from analysts, investors and the public. You can submit those questions to us in advance via X. number GinkgoResults or e-mail, investors at ginkgobioworks.com.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot